Health & Beauty

According to the report of Huacheng Import and Export Data Observation, on February 24, the Sinopharm Group's Sinopharm and GE Healthcare China signed an agreement in Beijing, announcing the establishment of a medical equipment joint venture controlled by the Chinese side in China, to build the world's leading production base and production line of medical imaging equipment, increase the domestic supply of high-end medical imaging equipment, and meet the growing demand of China's medical and health market.

This project is the first high-end medical imaging joint venture project controlled by the Chinese side, which will further improve the advanced level of China's medical equipment industry base and the modernization level of the industrial chain, and directly serve the Chinese medical market, improve the accessibility of medical imaging equipment, and will comprehensively promote the localization and replacement of high-end medical imaging equipment, and help the high-quality development of China's medical equipment industry.

According to the observation report of Huacheng Import and Export Data, in recent years, China's medical equipment innovation capacity has been continuously improved, the industrial scale has been accelerated, the industrial ecology has been continuously optimized, and the supply level has been significantly improved. According to the analysis of the Southern Institute of Pharmaceutical Economics of the State Food and Drug Administration, the scale of China's medical device market reached 1.3 trillion yuan last year, accounting for 27.5% of the global market. In the past five years, the annual compound growth rate has exceeded 12%.

"At the same time, the imbalance and inadequacy of China's medical equipment industry are still prominent, and there are still some weaknesses in key core technologies, key raw material industry chain, supply chain security and stability, and the promotion and application of innovative products." Xu Jinghe, deputy director of the State Drug Administration, said at the signing ceremony that the cooperation between China's medical equipment and GE will further enhance the basic upgrading of China's medical equipment industry Industrialization and modernization level, improve the accessibility of high-end medical equipment such as medical imaging, and promote the high-quality development of China's medical equipment industry. It is hoped that both sides will take the joint venture as a platform to accelerate the implementation and production of CT, magnetic resonance, ultrasound and other products in China.

According to the observation report of Huacheng Import and Export Data, Sinopharm Instruments is the strategic carrier of Sinopharm Group and Sinopharm Holdings' medical device sector, with a nationwide medical device supply system and an annual operating income of nearly 80 billion yuan.

"This time, Sinopharm Instruments and GE Healthcare China will work together to build a fully localized high-end medical equipment industrial platform, which is conducive to promoting the innovation of the cooperation mode between the international leading medical equipment enterprises and state-owned central enterprises, and deepening the in-depth and comprehensive cooperation between the two sides in capital and technology." Liu Jingzhen, secretary of the Party Committee and chairman of the Sinopharm Group, said that the two sides have worked hard to negotiate the central enterprise holding, foreign capital participation The joint venture cooperation mode is the first in the field of high-end medical equipment. On the basis of the dual introduction of capital and technology, it has achieved a breakthrough in the setting of equity ratio, enriched the channels and ways for international capital and international enterprises to participate in the reform of state-owned enterprises and cooperation between state-owned enterprises, further expanded the supply sources of international capital and advanced technology in China, and effectively improved the independent control of products in the field of key equipment.

According to the report of Huacheng Import and Export Data Observation, Sinopharm will build a world-class medical imaging production base, apply for the registration and listing of medical device products under the brand of Sinopharm. The initial cooperation includes CT and ultrasound series products, and will gradually develop to other imaging products such as magnetic resonance in the future. In addition to the third-level hospitals, the demand-side focuses on the centralized purchase of prefecture-level and lower-level hospitals and the construction of new medical infrastructure.

Zhang Yihao, president and CEO of GE Healthcare China, said that in the face of the future, the challenges of prevention and treatment of major diseases such as cancer, cardio-cerebrovascular disease and so on are still huge, especially in the vast grass-roots areas, rural revitalization is first to improve the level of prevention and treatment of major diseases of the grass-roots people. GE and Sinopharm will work together to provide more targeted and inclusive medical equipment to meet the urgent needs of China's medical and health care, so that more people can enjoy higher quality medical services. Huacheng Import and Export Data Observation Report.